In turn, VDR ligands inhibit TGF-β-induced liver fibrosis by binding to co-regulated genes such as Tgfb1, Mmp7 and Ctgf and reduce Smad3 occupancy at these sites10. The gene discussed is TGFB1; the disease is Hepatic fibrosis.